Build with KISHO Sign In Sign Up

Kisho

Cangene Corporation — Rare Disease Pipeline | Kisho | Kisho

Cangene Corporation

Other

4

Orphan Designations

0

FDA Approvals

13

Rare Diseases

0

News Articles

Disease	Drug(s)	Designation	Approved
Bloom syndrome	VARIZIG	Orphan Designation	-
Bruton-type agammaglobulinemia	HepaGam B	Orphan Designation	-
botulism	botulism antitoxin heptavalent (A, B, C, D, E, F, G) (Equine)	Orphan Designation	-
hereditary spastic paraplegia 23	VARIZIG	Orphan Designation	-
isotretinoin syndrome	VARIZIG	Orphan Designation	-
lymphoproliferative syndrome 2	VARIZIG	Orphan Designation	-
major depressive disorder	CNJ-016	Orphan Designation	-
malignant carotid body paraganglioma	CNJ-016	Orphan Designation	-
microvascular complications of diabetes, susceptibility	CNJ-016	Orphan Designation	-
post 5-alpha-reductase inhibitors treatment syndrome	CNJ-016	Orphan Designation	-
post-treatment Lyme disease syndrome	CNJ-016	Orphan Designation	-
treatment-refractory schizophrenia	CNJ-016	Orphan Designation	-
varicella, severe recurrent	VARIZIG	Orphan Designation	-

← Back to Companies